Perioperative Safety Evaluation of Gastrointestinal Surgery in Patients With Prosthetic Valves
DOI:
https://doi.org/10.1532/hsf.4533Keywords:
Heart Valve Prosthesis, Postoperative Complications, Hemorrhage, Anticoagulants, Digestive System Surgical ProceduresAbstract
Background: In patients with prosthetic valves, the perioperative outcomes, as well as the risk factors, following gastrointestinal surgery remain to be defined.
Methods: From January 2010 to March 2018, the clinical data of 69 cases with prosthetic valves after gastrointestinal surgery retrospectively were collected. Univariate and multivariate analysis were applied to identify the risk factors associated with significant bleeding events and non-hemorrhagic complications.
Results: Among 69 cases, 9 patients (13.0%) presented major bleeding events, and 21 patients (30.4%) presented non-hemorrhagic complications. Major bleeding events were significantly higher in patients with simple aortic valve replacement (AVR) than in other types of prosthetic valves (27.6% vs. 2.5%, P = 0.003), and there was no significant difference in the incidence of non-hemorrhagic complications. Simple AVR was the significant risk factor for major bleeding events (P = 0.043). Significant risk factors for non-hemorrhagic complications were operative duration ≥ 160 minutes (P = 0.021), duration from heart valve replacement to gastrointestinal surgery ≥ 84 months (P = 0.039), and simple AVR (P = 0.047).
Conclusion: The patients with simple AVR had a much higher bleeding risk following gastrointestinal surgery.
References
Baklanov DV, Kim S, Marso SP, Subherwal S, Rao SV. 2013. Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry. Circ Cardiovasc Interv. 6: 347-53.
Biteker M, Tekkesin AI, Can MM, Dayan A, Ilhan E, Turkmen FM. 2012. Outcome of noncardiac and nonvascular surgery in patients with mechanical heart valves. Am J Cardiol. 110: 562-7.
Carnicelli AP, O'Gara PT, Giugliano RP. 2016. Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation. Am J Cardiol. 118: 1419-26.
Cigarroa R, Elmariah S. 2018. Anticoagulation Management After Transcatheter and Surgical Valve Replacement. Curr Treat Options Cardiovasc Med. 20: 42.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, et al. 2009. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 250: 187-96.
Conte JV, Hermiller J, Jr., Resar JR, Deeb GM, Gleason TG, et al. 2017. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement. Semin Thorac Cardiovasc Surg. 29: 321-30.
de Siqueira Corradi MB, R DA, Duim E, Rodrigues CIS. 2020. Risk stratification for complications of laparoscopic cholecystectomy based on associations with sociodemographic and clinical variables in a public hospital. Am J Surg. 219: 645-50.
El Hajj SC, Eleid MF. 2019. Transcatheter Mitral Valve Replacement: An Update on the Current Literature. Curr Treat Options Cardiovasc Med. 21: 35.
Goodman SG, Wojdyla DM, Piccini JP, White HD, Paolini JF, et al. 2014. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol. 63: 891-900.
Goulart A, Ferreira C, Estrada A, Nogueira F, Martins S, et al. 2018. Early Inflammatory Biomarkers as Predictive Factors for Freedom from Infection after Colorectal Cancer Surgery: A Prospective Cohort Study. Surg Infect (Larchmt). 19: 446-50.
Gryaznov AA, Saeyeldin A, Abdelbaky M, Zafar MA, Tanweer M, et al. 2018. Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Therapeutic Morass. Cardiology. 140: 213-21.
Korteland NM, Etnel JRG, Arabkhani B, Mokhles MM, Mohamad A, et al. 2017. Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation. Eur Heart J. 38: 3370-77.
Labaf A, Grzymala-Lubanski B, Stagmo M, Lovdahl S, Wieloch M, et al. 2014. Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study. Thromb Res. 134: 354-9.
Labaf A, Svensson PJ, Renlund H, Jeppsson A, Sjalander A. 2016. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: A nationwide population-based study. Am Heart J. 181: 1-9.
McAlpine K, Breau RH, Knee C, Carrier M, Violette PD, et al. 2019. Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 166: 1084-91.
Mita K, Ito H, Murabayashi R, Sueyoshi K, Asakawa H, et al. 2012. Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents. Ann Surg Oncol. 19: 3745-52.
Sun JC, Davidson MJ, Lamy A, Eikelboom JW. 2009. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet. 374: 565-76.
Tabata N, Sugiura A, Tsujita K, Nickenig G, Sinning JM. 2020. Percutaneous interventions for mitral and tricuspid heart valve diseases. Cardiovasc Interv Ther. 35: 62-71.
Tanaka H, Tamura T, Toyokawa T, Muguruma K, Kubo N, et al. 2019. C-reactive protein elevation ratio as an early predictor of postoperative severe complications after laparoscopic gastrectomy for gastric cancer: a retrospective study. BMC Surg. 19: 114.
